14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

Trading levels for ADVM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 9.01 9.21 %
R2 8.77 6.34 %
R1 8.63 4.57 %
Current price: 8.25
Support S1 8.15 -1.17 %
S2 8.01 -2.95 %
S3 7.77 -5.82 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 9.53 15.52 %
R2 9.39 13.82 %
R1 9.19 11.39 %
Current price 8.25
Support S1 0 .
S2 0 .
S3 0 .

ADVM Predictions History

3 years ago
Vahid roozbahani predicted that ADVM for 2020-08-19 is going $18.00 (38.36%)

Rank:

4 years ago
JS predicted that ADVM for 2020-04-20 is going $12.65 (-10.03%)

4 years ago
تراحيب العتيبي predicted that ADVM for 2020-04-20 is going $14.90 (15.41%)

Rank:

4 years ago
Alan predicted that ADVM for 2020-01-21 is going $11.59 (-1.11%)

4 years ago
Alan predicted that ADVM for 2020-01-02 is going $11.99 (2.13%)

4 years ago
Alan predicted that ADVM for 2019-12-31 is going $11.48 (-0.35%)

4 years ago
JS predicted that ADVM for 2019-12-30 is going $10.95 (-2.41%)

4 years ago
Alan predicted that ADVM for 2019-12-30 is going $11.57 (3.21%)

5 years ago
GoldenNugget predicted that ADVM for 2019-05-07 is going $6.66 (-0.68%)

5 years ago
NameNotImportant predicted that ADVM for 2019-05-06 is going $6.83 (3.02%)

Click to get the best stock tips daily for free!

About ADVM

ADVM Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with U... ADVM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT